The Native American tribe wrapped up in litigation with generic pharmaceutical companies is trying to prove that its arrangement with Allergan (NYSE:AGN) reflects a legitimate move to boost its economy, according to court documents.
The St. Regis Mohawk Tribe of New York found itself it the middle of a controversial deal this year after it agreed to license the patents for a dry eye drug, Restasis, from Allergan in exchange for payments.
Get the full story at our sister site, Drug Delivery News.
The post Tribe taking steps to ‘ramp up’ drug patent business appeared first on MassDevice.
from MassDevice https://ift.tt/2x15d4z
Cap comentari:
Publica un comentari a l'entrada